Although new cases of Hepatitis-C have drastically decreased in the United States since peaking in the 1980’s, the blood-borne disease which primarily attacks and destroys the liver, kills more Americans annually than AIDS.
Andrew Pollack covers business and biotechnology for the New York Times. We read his article “Hepatitis-C, a Silent Killer, Meets Its Match,” in which Pollack describes a new series of treatments about to enter the market that could effectively do the impossible: wipe out Hep C.